CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis

[1]  R. Miller,et al.  Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis , 2009, Experimental Neurology.

[2]  V. Perry,et al.  Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.

[3]  M. Beal,et al.  Mitochondrial Approaches for Neuroprotection , 2008, Annals of the New York Academy of Sciences.

[4]  R. Ransohoff,et al.  Memory CD4+ T-Cell-Mediated Protection from Lethal Coronavirus Encephalomyelitis , 2008, Journal of Virology.

[5]  A. Billiau,et al.  How interferon-gamma keeps autoimmune diseases in check. , 2008, Trends in immunology.

[6]  C. Trebst,et al.  The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone‐induced demyelination , 2008, Glia.

[7]  M. Schwab,et al.  Nogo-A and Myelin-Associated Glycoprotein Differently Regulate Oligodendrocyte Maturation and Myelin Formation , 2008, The Journal of Neuroscience.

[8]  R. Ransohoff,et al.  Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. , 2008, Blood.

[9]  I. Ziabreva,et al.  Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.

[10]  T. Lane,et al.  The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease , 2008, The Journal of experimental medicine.

[11]  M. J. Cody,et al.  Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-α), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis , 2008, Innate immunity.

[12]  H. Iocca,et al.  TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model , 2008, Journal of Neuroimmunology.

[13]  R. Ransohoff.  Microgliosis: the questions shape the answers , 2007, Nature Neuroscience.

[14]  A. K. Hall,et al.  Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions , 2007, Annals of neurology.

[15]  H. Lassmann,et al.  Experimental models of multiple sclerosis. , 2007, Revue neurologique.

[16]  T. Owens,et al.  Microglial recruitment, activation, and proliferation in response to primary demyelination. , 2007, The American journal of pathology.

[17]  Kenneth J. Smith,et al.  Sodium Channels and Multiple Sclerosis: Roles in Symptom Production, Damage and Therapy , 2007, Brain pathology.

[18]  L. Pasquini,et al.  The Neurotoxic Effect of Cuprizone on Oligodendrocytes Depends on the Presence of Pro-inflammatory Cytokines Secreted by Microglia , 2007, Neurochemical Research.

[19]  D. Willenborg,et al.  Neuronal Nitric Oxide Synthase Plays a Key Role in CNS Demyelination , 2006, The Journal of Neuroscience.

[20]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[21]  D. Ron,et al.  Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress , 2006 .

[22]  R. Ransohoff,et al.  Severe Disease, Unaltered Leukocyte Migration, and Reduced IFN-γ Production in CXCR3−/− Mice with Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[23]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[24]  H. Lassmann,et al.  Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? , 2005, Acta Neuropathologica.

[25]  B. Trapp.  Pathogenesis of multiple sclerosis: The eyes only see what the mind is prepared to comprehend , 2004, Annals of neurology.

[26]  R. Ransohoff,et al.  Expression of Chemokine Receptors CCR1 and CCR5 Reflects Differential Activation of Mononuclear Phagocytes in Pattern II and Pattern III Multiple Sclerosis Lesions , 2004, Journal of neuropathology and experimental neurology.

[27]  R. Armstrong,et al.  Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter , 2002, The Journal of Neuroscience.

[28]  G. Matsushima,et al.  Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood–brain barrier , 2002, Journal of Neuroimmunology.

[29]  R. Ransohoff,et al.  The Chemokine Receptor CXCR2 Controls Positioning of Oligodendrocyte Precursors in Developing Spinal Cord by Arresting Their Migration , 2002, Cell.

[30]  D. Sammond,et al.  Alterations in metabolism and gene expression in brain regions during cuprizone‐induced demyelination and remyelination , 2002, Journal of neurochemistry.

[31]  D. Cook,et al.  Absence of Macrophage-Inflammatory Protein-1α Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier1 , 2001, The Journal of Immunology.

[32]  R. Ransohoff,et al.  Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury , 2001, Neuroreport.

[33]  C. Lucchinetti,et al.  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. , 2001, Trends in molecular medicine.

[34]  P. Morell,et al.  The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.

[35]  P. Ye,et al.  Interferon-γ Protects against Cuprizone-Induced Demyelination , 2000, Molecular and Cellular Neuroscience.

[36]  P. Ye,et al.  Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.

[37]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[38]  T. Owens,et al.  IFN-γ Shapes Immune Invasion of the Central Nervous System Via Regulation of Chemokines1 , 2000, The Journal of Immunology.

[39]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[40]  W. Cammer.  The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro , 1999, Journal of the Neurological Sciences.

[41]  R. Ransohoff,et al.  Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis. , 1999, Journal of neurovirology.

[42]  H. Lassmann,et al.  Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology , 1998, Brain pathology.

[43]  T. Owens,et al.  Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.

[44]  W. Wood,et al.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.

[45]  S. Ludwin,et al.  Evidence for a “dying‐back” gliopathy in demyelinating disease , 1981, Annals of neurology.

[46]  J. D. Kocsis,et al.  Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum Light-microscopic observations , 1979, Journal of the Neurological Sciences.

[47]  J. Rafael,et al.  Biochemical properties of liver megamitochondria induced by chloramphenicol or cuprizone. , 1977, Experimental cell research.